Anxin Ouyun Completes Angel Round of Financing

According to 36Kr.com, Anxin Ouyun, which is engaged in assisted reproduction in Europe, has closed its angel round financing with participation from the investor CRCM Ventures. The valuation of Anxin Ouyun is going to be more than 10 million yuan after the latest financing.

Proceeds of this financing will be used to improve the overseas service team with the corporate network of CRCM Ventures and introduce more high-quality medical resources for cooperation to further improve the customer experience.

Founded in 2019 as a medical service brand of Asia EU Baby d.o.o., Anxin Ouyun is a developer of medical technology designed to provide assisted reproduction solutions to Chinese customers. The company is headquartered in Croatia and has subsidiaries in Georgia, Serbia and Cyprus, and a market center in Beijing.

Anxin Ouyun cooperates with the leading hospitals in Europe to provide test tube baby services to Chinese customers with the success rate of single test tube up to 67%, enabling customers to gain technical support for pregnancy. Anxin Ouyun has set up a company in Europe under the regulation of GDPR (General Data Protection Regulation), which ensures good protection of personal privacy.

In the cross-border assisted reproduction industry, the product price of Anxin Ouyun is relatively low. At the same time, the medical resources connected with Anxin Ouyun can still maintain at a high level.

CRCM Ventures backs ambitious early-stage companies, setting the stage for emerging technologies. It maintains a global presence by being deeply rooted in Silicon Valley and China. Since 2004, the company has invested in over 200+ companies resulting in 5 IPOs and 18 acquisitions. 

In 2019, CRCM Ventures launched its 5th fund to focus on consumer/media, healthcare/wellness, frontier and blockchain technologies.